Organicell Regenerative Medicine (BPSR) SEC Filings & 10K Form

$1.10
-0.02 (-1.79%)
(As of 05/9/2024 ET)

Recent Organicell Regenerative Medicine SEC Filings

DateFilerForm TypeView
04/02/2024
3:10 PM
Bretz Charles Luther (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:10 PM
GLAUSER STEVEN JERRY (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:11 PM
Stearn Leathem S (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:11 PM
Singh Gurvinder Pal (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:36 PM
Organicell Regenerative Medicine (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/20/2023
5:30 AM
Organicell Regenerative Medicine (Filer)
Form DEF 14C
12/12/2023
3:15 PM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
4:00 PM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
3:29 PM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2023
5:56 AM
Organicell Regenerative Medicine (Filer)
Form PRER14C
09/28/2023
1:54 PM
Organicell Regenerative Medicine (Filer)
Form PRE 14C
09/14/2023
3:15 PM
Organicell Regenerative Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/11/2023
4:00 PM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2023
3:15 PM
Organicell Regenerative Medicine (Issuer)
Skycrest Holdings, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2023
8:00 AM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
7:45 AM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2023
3:35 PM
Leider Harry L. (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/09/2023
3:35 PM
Golub Howard Lawrence (Reporting)
Organicell Regenerative Medicine (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2023
3:53 PM
Organicell Regenerative Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (OTCMKTS:BPSR) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners